Uğur Şahin, BioNTech CEO (Sebastian Gollnow/picture-alliance/dpa/AP Images)

BioN­Tech to in­crease mR­NA vac­cine foot­print in Africa with $145M in­vest­ment

Mod­er­na may be hold­ing back its plans for mR­NA vac­cine pro­duc­tion in Africa, but Ger­many’s BioN­Tech is fill­ing in the space with an ex­pand­ed part­ner­ship …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.